89 related articles for article (PubMed ID: 15256814)
1. Impact of different immunosuppressive regimens on antigen-presenting blood cells in kidney transplant patients.
Scherberich JE; Estner H; Segerer W
Kidney Blood Press Res; 2004; 27(3):177-80. PubMed ID: 15256814
[TBL] [Abstract][Full Text] [Related]
2. CD16⁺ monocytes with smooth muscle cell characteristics are reduced in human renal chronic transplant dysfunction.
Boersema M; van den Born JC; van Ark J; Harms G; Seelen MA; van Dijk MC; van Goor H; Navis GJ; Popa ER; Hillebrands JL
Immunobiology; 2015 May; 220(5):673-83. PubMed ID: 25476849
[TBL] [Abstract][Full Text] [Related]
3. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.
Rogacev KS; Seiler S; Zawada AM; Reichart B; Herath E; Roth D; Ulrich C; Fliser D; Heine GH
Eur Heart J; 2011 Jan; 32(1):84-92. PubMed ID: 20943670
[TBL] [Abstract][Full Text] [Related]
4. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
[TBL] [Abstract][Full Text] [Related]
5. Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population.
Coen PM; Flynn MG; Markofski MM; Pence BD; Hannemann RE
Metabolism; 2010 Dec; 59(12):1775-83. PubMed ID: 20580035
[TBL] [Abstract][Full Text] [Related]
6. Increased Toll-like receptor-2 expression on nonclassic CD16+ monocytes from patients with inflammatory stage of Eales' disease.
Sen A; Chowdhury IH; Mukhopadhyay D; Paine SK; Mukherjee A; Mondal LK; Chatterjee M; Bhattacharya B
Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6940-8. PubMed ID: 21791592
[TBL] [Abstract][Full Text] [Related]
7. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population.
Rossol M; Kraus S; Pierer M; Baerwald C; Wagner U
Arthritis Rheum; 2012 Mar; 64(3):671-7. PubMed ID: 22006178
[TBL] [Abstract][Full Text] [Related]
8. CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation.
Sekerkova A; Krepsova E; Brabcova E; Slatinska J; Viklicky O; Lanska V; Striz I
BMC Immunol; 2014 Feb; 15():4. PubMed ID: 24499053
[TBL] [Abstract][Full Text] [Related]
9. Human monocyte heterogeneity--a nephrological perspective.
Rogacev KS; Heine GH
Nephrol Ther; 2010 Jul; 6(4):219-25. PubMed ID: 20447885
[TBL] [Abstract][Full Text] [Related]
10. Elevated CD14++CD16- monocytes predict cardiovascular events.
Berg KE; Ljungcrantz I; Andersson L; Bryngelsson C; Hedblad B; Fredrikson GN; Nilsson J; Björkbacka H
Circ Cardiovasc Genet; 2012 Feb; 5(1):122-31. PubMed ID: 22238190
[TBL] [Abstract][Full Text] [Related]
11. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
12. Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in haemodialysis patients.
Merino A; Alvarez-Lara MA; Ramirez R; Carracedo J; Martin-Malo A; Aljama P
Nephrol Dial Transplant; 2012 Jul; 27(7):2907-12. PubMed ID: 22247233
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
[TBL] [Abstract][Full Text] [Related]
14. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
[TBL] [Abstract][Full Text] [Related]
15. Bacterial DNA and endothelial damage in haemodialysis patients.
Merino A; Nogueras S; García-Maceira T; Rodríguez M; Martin-Malo A; Ramirez R; Carracedo J; Aljama P
Nephrol Dial Transplant; 2008 Nov; 23(11):3635-42. PubMed ID: 18511607
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of Monocyte Derived Dendritic Cells in End Stage Renal Disease is Skewed Towards Accelerated Maturation.
Dopheide JF; Zeller GC; Kuhlmann M; Girndt M; Sester M; Sester U
Adv Clin Exp Med; 2015; 24(2):257-66. PubMed ID: 25931358
[TBL] [Abstract][Full Text] [Related]
17. CD14++CD16+ monocytes in patients with acute ischaemic heart failure.
Wrigley BJ; Shantsila E; Tapp LD; Lip GY
Eur J Clin Invest; 2013 Feb; 43(2):121-30. PubMed ID: 23240665
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocyte subsets with different dialyzers.
Griveas I; Visvardis G; Sakellariou G; Passadakis P; Thodis I; Vargemezis V; Pavlitou A; Fleva A
Ren Fail; 2006; 28(6):493-9. PubMed ID: 16928619
[TBL] [Abstract][Full Text] [Related]
19. Selective developmental defects of cord blood antigen-presenting cell subsets.
Drohan L; Harding JJ; Holm B; Cordoba-Tongson E; Dekker CL; Holmes T; Maecker H; Mellins ED
Hum Immunol; 2004 Nov; 65(11):1356-69. PubMed ID: 15556686
[TBL] [Abstract][Full Text] [Related]
20. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.
Kawanaka N; Yamamura M; Aita T; Morita Y; Okamoto A; Kawashima M; Iwahashi M; Ueno A; Ohmoto Y; Makino H
Arthritis Rheum; 2002 Oct; 46(10):2578-86. PubMed ID: 12384915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
